December 2023, Vol 311, No 7980
Top news stories
Fewer than 5,000 people prescribed anticholesterol drug inclisiran in primary care as of July 2023
Pharmacy technicians may prepare and dispense medicines without supervision under government proposals
Life cycle adjustment left out of statutory scheme on pricing of NHS medicines
Features
Revisiting 2023: a look back at the year in pharmacy
How has 2023 stacked up for the pharmacy sector?
Inclisiran: the ‘extremely unusual’ political influence behind the novel drug’s approval
Routine delays: the cancer services struggling to treat patients on time
Opinion
PJ view: Transparency in the science behind government policy is vital
The vision for supervision
How we are igniting change through the chief pharmaceutical officer’s Fellowship scheme
Elevating research within pharmacy
Community pharmacies’ full potential is trapped in an iron cage of bureaucracy
Pharmacy has a role in innovation adoption in healthcare systems
Learning & CPD
Learning and CPD: 2023 in review
Top ten articles of 2023 from the Royal Pharmaceutical Society’s research journals
Case-based learning: testosterone deficiency
Introduction to clinical assessment for prescribers
Test yourself: the 2023 CPD and Learning quiz
Pharmaceutical considerations for fracture management in adults
Prostate cancer: recognition and diagnosis
Women to Watch
Exceptional pharmacy professionals hailed in The Pharmaceutical Journal’s 2023 ‘Women to Watch’ list
Abeer Aamir
Ifesinachi Anyamene
Chloe Barclay
Elaine Ferguson
Maryam Jetha
